About ASPIRING

ASPIRING is an international study, testing whether aspirin and clopidogrel prevent strokes, heart attacks, and death after brain haemorrhage.

Please visit the sections below to find out more about these aspects of the study.

Brain haemorrhage

Stroke due to spontaneous bleeding into the brain, known as “brain haemorrhage”, affects more than 3 million people in the world each year.

Antiplatelet medicines

Clinical studies have found that people who have had a heart attack or stroke benefit from antiplatelet medicines like aspirin and clopidogrel.

Clinical trials

Studies called randomised controlled studies are the fairest tests of treatments.

The ASPIRING study

This study aims to produce reliable information about whether aspirin or clopidogrel help people after brain haemorrhage.

Study hospitals

Hospitals where investigators will enrol participants in ASPIRING.

Low angle view of hands of multiracial group of people working with documents on a table

Our team

Find out more about the people behind the ASPIRING trial

At least 6 people sitting around a board room table.

Patient and public involvement and engagement

ASPIRING has a Patient and public involvement and engagement (PPIE) Advisory Group (PAG) in the UK to oversee the global progress of the study and advise on UK issues.

Tiny white and orange caution cone placed on top of a keyboard

Data protection/privacy

All the information we collect during the study will be kept confidential.

Pair of spectacles placed on an opened book

Scientific publications

This is a selected list of relevant publications from the research team conducting ASPIRING.